183 related articles for article (PubMed ID: 1643607)
21. Imaging of medullary carcinoma of the thyroid using 111In-labelled anti-CEA monoclonal antibody fragments.
O'Byrne KJ; Hamilton D; Robinson I; Sweeney E; Freyne PJ; Cullen MJ
Nucl Med Commun; 1992 Mar; 13(3):142-8. PubMed ID: 1557212
[TBL] [Abstract][Full Text] [Related]
22. Detection of occult tumor using indium 111-labeled anticarcinoembryonic antigen antibodies.
Halpern SE; Dillman RO; Amox D; Hagan PL; Burks R; Dillman J; Perdikakis B; Merchant B; Frincke J; Schweighardt S
Arch Surg; 1992 Sep; 127(9):1094-100. PubMed ID: 1514913
[TBL] [Abstract][Full Text] [Related]
23. Initial clinical study of indium-111-labeled clone 110 anticarcinoembryonic antigen antibody in patients with colorectal cancer.
Griffin TW; Brill AB; Stevens S; Collins JA; Bokhari F; Bushe H; Stochl MC; Gionet M; Rusckowski M; Stroupe SD
J Clin Oncol; 1991 Apr; 9(4):631-40. PubMed ID: 2066759
[TBL] [Abstract][Full Text] [Related]
24. Immunoscintigraphy of adenocarcinomas by means of radiolabeled F(ab')2 fragments of an anti-carcinoembryonic antigen monoclonal antibody: a multicenter study.
Siccardi AG; Buraggi GL; Callegaro L; Colella AC; De Filippi PG; Galli G; Mariani G; Masi R; Palumbo R; Riva P
Cancer Res; 1989 Jun; 49(11):3095-103. PubMed ID: 2655889
[TBL] [Abstract][Full Text] [Related]
25. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G
Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575
[TBL] [Abstract][Full Text] [Related]
26. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
Jakowatz JG; Beatty BG; Vlahos WG; Porudominsky D; Philben VJ; Williams LE; Paxton RJ; Shively JE; Beatty JD
Cancer Res; 1985 Nov; 45(11 Pt 2):5700-6. PubMed ID: 4053043
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specific, murine monoclonal antibody, MN-14.
Sharkey RM; Goldenberg DM; Murthy S; Pinsky H; Vagg R; Pawlyk D; Siegel JA; Wong GY; Gascon P; Izon DO
Cancer; 1993 Mar; 71(6):2082-96. PubMed ID: 8443758
[TBL] [Abstract][Full Text] [Related]
28. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
[TBL] [Abstract][Full Text] [Related]
29. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
[TBL] [Abstract][Full Text] [Related]
30. Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')2 (FO23C5) in CEA serum-negative colorectal cancer patients.
Roselli M; Guadagni F; Buonomo O; Belardi A; Vittorini V; Cavazzana A; Spagnoli LG; Cipriani C; Casciani CU
Anticancer Res; 1996; 16(2):883-9. PubMed ID: 8687145
[TBL] [Abstract][Full Text] [Related]
31. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
[TBL] [Abstract][Full Text] [Related]
32. Radioimmunoscintigraphy with 111In labelled monoclonal antibody fragments (F(ab')2 BW 431/31) against CEA: radiolabelling, antibody kinetics and distribution, findings in tumour and non-tumour patients.
Bares R; Fass J; Truong S; Buell U; Schumpelick V
Nucl Med Commun; 1989 Sep; 10(9):627-41. PubMed ID: 2616103
[TBL] [Abstract][Full Text] [Related]
33. Improved tumor detection by anti-CEA chimeric Fab oligomers with disulfide linkages in a pancreatic-carcinoma-xenograft model.
Kamigaki T; Yamamoto M; Ohyanagi H; Ohya M; Kono A; Ohtani W; Narita Y; Ohkubo M; Ohmura T; Saitoh Y
Int J Cancer; 1996 Apr; 66(2):261-7. PubMed ID: 8603822
[TBL] [Abstract][Full Text] [Related]
34. Radiolocalisation of an anti-CEA monoclonal antibody (FO23C5) and its fragments in a colon carcinoma xenograft model.
Rowlinson G; Paganelli G; Snook D; Epenetos AA
Int J Biol Markers; 1988; 3(4):259-64. PubMed ID: 3235854
[TBL] [Abstract][Full Text] [Related]
35. Detection of suspected primary lung cancer by scintigraphy with indium-111-anti-carcinoembryonic antigen monoclonal antibodies (type F023C5).
Biggi A; Buccheri G; Ferrigno D; Viglietti A; Farinelli MC; Comino A; Leone A; Quaranta M; Taviani M
J Nucl Med; 1991 Nov; 32(11):2064-8. PubMed ID: 1941139
[TBL] [Abstract][Full Text] [Related]
36. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
[TBL] [Abstract][Full Text] [Related]
37. Tumor scintigraphy with 131I anti CEA monoclonal antibodies and F(ab')2 in colorectal cancer.
Henze E; Kübel R; Waitzinger J; Büchler M; Adam WE; Beger HG
Eur J Nucl Med; 1987; 13(3):125-9. PubMed ID: 3622555
[TBL] [Abstract][Full Text] [Related]
38. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.
Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C
J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546
[TBL] [Abstract][Full Text] [Related]
39. Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
Wong JY; Chu DZ; Williams LE; Yamauchi DM; Ikle DN; Kwok CS; Liu A; Wilczynski S; Colcher D; Yazaki PJ; Shively JE; Wu AM; Raubitschek AA
Clin Cancer Res; 2004 Aug; 10(15):5014-21. PubMed ID: 15297402
[TBL] [Abstract][Full Text] [Related]
40. 111In-cetuximab-F(ab')2 SPECT and 18F-FDG PET for prediction and response monitoring of combined-modality treatment of human head and neck carcinomas in a mouse model.
van Dijk LK; Boerman OC; Franssen GM; Kaanders JH; Bussink J
J Nucl Med; 2015 Feb; 56(2):287-92. PubMed ID: 25552666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
